Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis Academic Article uri icon

Overview

MeSH Major

  • Acetylcysteine
  • Free Radical Scavengers
  • Idiopathic Pulmonary Fibrosis

abstract

  • As compared with placebo, acetylcysteine offered no significant benefit with respect to the preservation of FVC in patients with idiopathic pulmonary fibrosis with mild-to-moderate impairment in lung function. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov number, NCT00650091.).

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4116664

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1401739

PubMed ID

  • 24836309

Additional Document Info

start page

  • 2093

end page

  • 101

volume

  • 370

number

  • 22